abu bakar sulong, norfilza mohd mokhtar, mohamad nasir sahfiee, yap wei boon, caryn chan mei hsein, mohd kaisan mahadi, mohamad aimanuddin mohtar.  (2022).  impak: kluster kesihatan & perubatan termaju.  - impak: kluster kesihatan & perubatan termaju.  1-44. 

mohamad aimanuddin mohtar, ryia illani mohd yunos, nor azian abdul murad.  (2022).  laboratory manual for biosafety & biosecurity in umbi.  - .  1-21. 

saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  crispr-cas9 experimental workflow part ii.  - .  1-77. 

saiful effendi bin syafruddin, encik muhiddin bin ishak, mohamad aimanuddin bin mohtar.  (2022).  elucidating the mode of pdgfb-mediated activation of mtorc1 signalling pathway in clear cell renal cell carcinoma.  - .  1-7. 

syazalina zahari , saiful effendi syafruddin, low teck yew , delphine fessart , ted hupp, m. aiman mohtar.  (2022).  elucidating the impact of crispr cas9 mediated agr2 knockout in the tumour microenvironment of breast cancer cells.  - the 46th annual conference of the malaysian society for biochemistry and molecular biology 2022 (msb.  1. 

nurul nadia mohamad zamberi, asmaa y. abuhamad, teck yew low, m. aiman mohtar, and saiful effendi syafruddin.  (2022).  the epigenetic modulators brd4 and p300 support klf6 super enhancer activity in promoting renal tumorigenesis.  - 46th annual conference of the malaysian society for biochemistry and molecular biology 2022 (msbmb46).  1-7. 

mohamad aimanuddin mohtar, saiful effendi syafruddin.  (2022).  protein agr2: bio penanda baru untuk pengesanan awal kanser.  - impak: kluster kesihatan & perubatan termaju.  28-29. 

saiful effendi syafruddin, mohamad aimanuddin mohtar.  (2022).  bengkel crispr gene editing di institute of medical research (imr).  - .  1-3. 

asmaa y. i. abuhamad, mohamad aimanuddin mohtar, asilah ahmad tajudin, amir syahir bin amir hamzah, saiful effendi syafruddin.  (2021).  crispr-mediated generation of in vitro breast cancer models to study p53 ain-of-function mutation.  - 4th international conference on molecular biology &biotechnology.  1-19. 

nisa syakila a rahman, saiful effendi syafruddin, teck yew low, m. aiman mohtar.  (2021).  functional interrogation of crispr-cas9 mediated agr2 knockout in metastatic triple negative breast cancer cells.  - ysn-asm international scientific virtual conference (isvc) 2021.  1. 

mohamad aimanuddin bin mohtar;a. rahman bin a. jamal;siti nurmi binti nasir;low teck yew.  (2021).  devising synthetic anti-cancer tools targeting pro-oncogenic agr2 protein.  - .  . 

siti nur hasanah mohd yusuf, asmaa y. abuhamad, ling sheen, nurul nadia zamberi, mohamad aimanuddin mohtar and saiful effendi syafruddin.  (2021).  pdgfb paracrine signalling fuels growth promoting mtorc1 hyperactivation in clear cell renal cell carcinoma (ccrcc).  - international conference on drug discovery and translational medicine 2021 (icddtm 21).  1-14. 

nadiah binti abu;a. rahman bin a. jamal;fuad bin ismail;luqman bin mazlan;nurul syakima binti ab mutalib;mohamad aimanuddin bin mohtar.  (2021).  understanding the effects of chemotherapy-induced exosomes (chemoexosomes) on human t cells subsets .  - .  . 

asmaa y. abuhamad, ling sheen, safaa m. naes, siti nur hasanah yusuf, nurul nadia zamberi, asilah ahmad tajudin, mohamad aimanuddin mohtar, amir syahir bin amir hamzah, saiful effendi syafruddin.  (2021).  crispr gene editing the generation of genetically engineered breast cancer cells for interrogating the l194f p53 mutation.  - international conference on drug discovery and translational medicine 2021 (icddtm 21).  1-14. 

safaa m. naes, sharaniza ab. rahim, musalmah binti mazlan, saiful effendi syafruddin, m. aiman mohtar, amirah abdul rahman.  (2020).  ent2 gene expression in the different stages of colorectal cancer.  - international e-conference on biotechnology, bioinformatics, and biomedicine.  1. 

mohamad aimanuddin mohtar.  (2020).  our winning proposals: biotech grants lift labs around the globe.  - research professional news.  1-2. 

mohamad aimanuddin mohtar, saiful effendi syafruddin, amir syahir bin amir hamzah.  (2020).  teknologi penyuntingan gen crispr dan teknik terbaharu pengesanan covid-19.  - majalahsains.com.  1-2. 

mohamad aimanuddin mohtar, saiful effendi syafruddin,.  (2020).  crispr protocol for crispr-mediated gene editing in human cell lines workshop 2019.  - .  1-24. 

mohamad aimanuddin mohtar.  (2020).  research halts at malaysian universities due to covid-19.  - research professional news.  1-2. 

tan shing cheng, m aiman mohtar, kamariah ibrahim.  (2020).  association of mthfr rs1801131 polymorphism with risk of meningioma and glioma: a meta-analysis.  - asian regional conference on systems biology.  107. 

m. aiman mohtar, teck yew low, borek vojtesek, rahman jamal and ted hupp.  (2019).  the development of a synthetic scfv monoclonal antibody targeting pro-oncogenic agr2.  - international conference on drug discovery and translational medicine 2018 (icddtm '18).  128. 

m. aiman mohtar, siti nurmi nasir, ted r. hupp.  (2019).  devising synthetic anti-cancer tools targeting pro-oncogenic agr2 protein.  - the international conference on molecular diagnostics & biomarker discovery 2019 (mdbd2019).  1-2. 

nur syahada abd razak, norahayu othman. siti nurmi nasir, zairul azwan mohd azman, nurul syakima ab mutalib, mohamad aimanuddin mohtar, nadiah abu.  (2019).  the effects of chemotherapy-induced extracellular vesicles (chemo-evs) on cd8 t cells.  - 1st malaysian association of cancer research scientific conference.  49. 

m. aiman mohtar.  (2018).  crispr genome editing: my experience.  - crispr gene editing & multiplex immunoassay in conjunction with international conference on drug discovery and translational medicine 2018 (icddtm '18).  . 

m. aiman mohtar, rory duncan, borek vojtesek & ted r hupp.  (2018).  pro-oncogenic protein agr2 controls epcam expression and receptor presentation to the cell surface.  - stem cell and cancer symposium 2018.  . 

m. aiman mohtar, lenka hernychova, borek vojtesek, ted r. hupp.  (2018).  quantitative mass spectrometry analysis of agr2-reconstituted cancer cell identifies multiple agr2 interacting proteins.  - 8th regional conference on molecular medicine (rcmm) in conjunction with 4th national conference for cancer research (nccr).  . 

m. aiman mohtar, teck yew low, borek vojtesek, rahman jamal and ted hupp.  (2018).  frontiers in pharmacology.  - international conference on drug discovery and translational medicine 2018 (icddtm '18).  . 

m. aiman mohtar, rory duncan, borek vojtesek, ted r hupp.  (2018).  pro-oncogenic protein agr2 controls epcam expression and receptor presentation to the cell surface.  - stem cell and cancer symposium (sccs) 2018.  1-2.